{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:32:13Z","timestamp":1780054333376,"version":"3.54.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.dld.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T01:18:53Z","timestamp":1647911933000},"page":"713-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"54","author":[{"given":"Deepak","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuraag","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardhu Neelam","family":"Bharath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arup","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2472-3409","authenticated-orcid":false,"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dld.2022.03.005_bib0001","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2050640620972602","article-title":"Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"9","author":"Singh","year":"2021","journal-title":"United Eur Gastroenterol J"},{"issue":"4","key":"10.1016\/j.dld.2022.03.005_bib0002","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/gutjnl-2020-324000","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting","volume":"70","author":"Siegel","year":"2021","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.dld.2022.03.005_bib0003","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S2468-1253(21)00024-8","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British society of gastroenterology inflammatory bowel disease section and IBD clinical research group position statement","volume":"6","author":"Alexander","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.dld.2022.03.005_bib0004","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2468-1253(21)00374-5","article-title":"Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease","volume":"6","author":"Alexander","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2022.03.005_bib0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2021.09.055","article-title":"Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"162","author":"Sakuraba","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2022.03.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102927","article-title":"Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: systematic review and meta-analysis","volume":"21","author":"Jena","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.dld.2022.03.005_bib0007","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.cgh.2021.02.004","article-title":"COVID-19 vaccination intent and perceptions among patients with inflammatory bowel diseases","volume":"19","author":"Dalal","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.005_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.731578","article-title":"The COVID-19 vaccination hesitancy among the people with inflammatory bowel disease in China: a questionnaire study","volume":"9","author":"Wu","year":"2021","journal-title":"Front Public Health"},{"issue":"15","key":"10.1016\/j.dld.2022.03.005_bib0009","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2022.03.005_bib0010","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2022.03.005_bib0011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with {R}: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.dld.2022.03.005_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.dld.2022.03.005_bib0013","unstructured":"Wells G., Shea B., O'Connell D., Peterson J., Welch V., Losos M., Tugwell P.: The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013, http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.dld.2022.03.005_bib0014","first-page":"izab207","article-title":"Antibody responses to SARS-CoV-2 after infection or vaccination in children and young adults with inflammatory bowel disease","author":"Dailey","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.dld.2022.03.005_bib0015","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.14309\/ajg.0000000000001342","article-title":"Adverse events after SARS-CoV-2 mRNA vaccination among patients with inflammatory bowel disease","volume":"116","author":"Botwin","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.dld.2022.03.005_bib0016","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.04.025","article-title":"Serologic response to messenger RNA coronavirus disease 2019 vaccines in inflammatory bowel disease patients receiving biologic therapies","volume":"161","author":"Wong","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2022.03.005_bib0017","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.gastro.2021.10.029","article-title":"Lower serologic response to COVID-19 mRNA Vaccine in patients with inflammatory bowel diseases treated with anti-TNF\u03b1","volume":"162","author":"Edelman-Klapper","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.03.005_bib0018","first-page":"jjab189","article-title":"\"Safety of COVID-19 vaccination in inflammatory bowel disease patients on biologic therapy\"","author":"Garrido","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2022.03.005_bib0019","article-title":"Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD","author":"Cannatelli","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.03.005_bib0020","first-page":"izab302","article-title":"Impact of SARS-CoV-2 vaccination on inflammatory bowel disease activity and development of vaccine-related adverse events: results from PREVENT-COVID","author":"Weaver","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2022.03.005_bib0021","doi-asserted-by":"crossref","first-page":"S453","DOI":"10.14309\/01.ajg.0000777332.80634.a8","article-title":"S950-Symptomology following SARS-CoV-2 mRNA vaccination among patients with inflammatory bowel disease relative to healthcare workers","volume":"116","author":"Mujukian","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.03.005_bib0022","article-title":"Antibody response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease - results of a single-center cohort study in a tertiary hospital in Germany","author":"Classen","year":"2021","journal-title":"Digit Distrib"},{"issue":"2","key":"10.1016\/j.dld.2022.03.005_bib0023","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/ced.14932","article-title":"Comment on \u2018Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?\u2019: type I interferons as possible link between COVID-19 vaccine and vitiligo","volume":"47","author":"Abdullah","year":"2021","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.dld.2022.03.005_bib0024","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S2468-1253(21)00194-1","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel disease \u2013 authors' reply","volume":"6","author":"Alexander","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.005_bib0025","article-title":"Anti-SARS-CoV-2 vaccination and antibody response in patients with inflammatory bowel disease on immune-modifying therapy: prospective single-tertiary study","author":"Cerna","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.dld.2022.03.005_bib0026","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41575-021-00420-w","article-title":"SARS-CoV-2 vaccination in IBD: more pros than cons","volume":"18","author":"D'Amico","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2022.03.005_bib0027","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/apt.16590","article-title":"Review article: vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic","volume":"54","author":"Doherty","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.dld.2022.03.005_bib0028","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1016\/S2665-9913(21)00247-2","article-title":"COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses","volume":"3","author":"Fagni","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"10.1016\/j.dld.2022.03.005_bib0029","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.dld.2020.05.037","article-title":"Screening for active COVID-19 infection prior to biologic therapy in IBD patients: let's not increase our uncertainty without reducing our concerns","volume":"52","author":"Festa","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.dld.2022.03.005_bib0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S2468-1253(21)00148-5","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel disease","volume":"6","author":"Garrido","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2022.03.005_bib0031","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1053\/j.gastro.2021.06.014","article-title":"COVID-19 vaccination is safe and effective in patients with inflammatory bowel disease: analysis of a large multi-institutional research network in the United States","volume":"161","author":"Hadi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.03.005_bib0032","doi-asserted-by":"crossref","first-page":"S1027","DOI":"10.14309\/01.ajg.0000783228.57948.29","article-title":"New diagnosis of severe ulcerative colitis immediately following mRNA-1273 SARS-CoV2 vaccination","volume":"116","author":"Kothadia","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.03.005_bib0033","doi-asserted-by":"crossref","first-page":"S427","DOI":"10.14309\/01.ajg.0000777148.70332.5d","article-title":"Gastrointestinal symptoms in patients with inflammatory bowel disease after SARS-CoV-2 mRNA vaccination","volume":"116","author":"Kumar","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.03.005_bib0034","doi-asserted-by":"crossref","first-page":"S1025","DOI":"10.14309\/01.ajg.0000783200.55430.92","article-title":"Acute exacerbation of Crohn's disease after COVID-19 Pfizer vaccine","volume":"116","author":"Latypov","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2022.03.005_bib0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.gastro.2021.05.030","article-title":"COVID-19 vaccination and inflammatory bowel disease: desired antibody responses, future directions, and a note of caution","volume":"162","author":"Levine","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.03.005_bib0036","doi-asserted-by":"crossref","unstructured":"Li D, Debbas P, Cheng S, Braun J, McGovern DPB, Melmed GY. Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease. medRxiv [Preprint]. 2021 Dec 7:2021.12.05.21266089. doi:10.1101\/2021.12.05.21266089. PMID: 34909797; PMCID: PMC8669864.","DOI":"10.1101\/2021.12.05.21266089"},{"issue":"3","key":"10.1016\/j.dld.2022.03.005_bib0037","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2020.10.013","article-title":"Winter is coming! Clinical, immunologic, and practical considerations for vaccinating patients with inflammatory bowel disease during the coronavirus disease-2019 pandemic","volume":"160","author":"Melmed","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.03.005_bib0038","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1093\/jcag\/gwab033","article-title":"Crohn's and colitis Canada's 2021 impact of COVID-19 and inflammatory bowel disease in Canada: COVID-19 vaccines-biology, current evidence and recommendations","volume":"4","author":"Murthy","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2022.03.005_bib0039","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ygh2.473","article-title":"SARS-CoV-2 vaccination in patients with inflammatory bowel disease","volume":"3","author":"Prentice","year":"2021","journal-title":"GastroHep"},{"issue":"12","key":"10.1016\/j.dld.2022.03.005_bib0040","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.14309\/ajg.0000000000001416","article-title":"SARS-CoV-2 immunization in patients with inflammatory bowel disease may result in disease flares","volume":"116","author":"Sangha","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2022.03.005_bib0041","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40164-021-00235-0","article-title":"COVID-19 vaccination associated severe immune thrombocytopenia","volume":"10","author":"Shah","year":"2021","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"10.1016\/j.dld.2022.03.005_bib0042","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/gutjnl-2020-324000","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting","volume":"70","author":"Siegel","year":"2021","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.dld.2022.03.005_bib0043","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/ibd\/izab194","article-title":"Seroconversion following SARS-CoV-2 infection or vaccination in pediatric IBD patients","volume":"27","author":"Spencer","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.dld.2022.03.005_bib0044","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2021.10.004","article-title":"COVID-19 mRNA vaccine short-term safety in patients with inflammatory bowel disease","volume":"162","author":"Spiera","year":"2022","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.dld.2022.03.005_bib0045","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/ibd\/izab094","article-title":"COVID-19 vaccination in patients with inflammatory bowel disease and history of reaction to injectable therapies","volume":"27","author":"Squire","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.dld.2022.03.005_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/life11111220","article-title":"Vaccination against SARS-CoV-2 in patients with inflammatory bowel diseases: where do we stand?","volume":"11","author":"Tepasse","year":"2021","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.dld.2022.03.005_bib0047","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jcag\/gwaa046","article-title":"COVID-19 vaccination in patients with inflammatory bowel disease: communiqu\u00e9 from the canadian association of gastroenterology","volume":"4","author":"Tse","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2022.03.005_bib0048","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MPG.0000000000003260","article-title":"Severe acute respiratory syndrome coronavirus 2 vaccination for paediatric patients with inflammatory bowel diseases","volume":"73","author":"Veereman","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"10.1016\/j.dld.2022.03.005_bib0049","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ecco-jcc\/jjab046","article-title":"SARS-CoV-2 vaccination in IBD: past lessons, current evidence, and future challenges","volume":"15","author":"Wellens","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.dld.2022.03.005_bib0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/ibd\/izab172","article-title":"COVID-19 vaccination willingness and hesitancy in patients with inflammatory bowel diseases: analysis of determinants in a national survey of the Italian IBD patients\u2019 association","volume":"28","author":"Costantino","year":"2022","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.dld.2022.03.005_bib0051","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1093\/ibd\/izab133","article-title":"Acceptance of SARS-CoV-2 vaccination among a cohort of IBD patients from Southern Italy: a cross-sectional survey","volume":"27","author":"Crispino","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2022.03.005_bib0052","first-page":"1","article-title":"COVID-19 vaccination in patients with inflammatory bowel disease: a survey from China","author":"Dai","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.dld.2022.03.005_bib0053","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822002109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822002109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:20:00Z","timestamp":1761625200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865822002109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1590865822002109"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.03.005","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}